Home/Filings/4/0000950170-25-108969
4//SEC Filing

Sprecher Jeffrey C 4

Accession 0000950170-25-108969

CIK 0001571949other

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 4:30 PM ET

Size

28.9 KB

Accession

0000950170-25-108969

Insider Transaction Report

Form 4
Period: 2025-08-12
Sprecher Jeffrey C
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2025-08-12$182.07/sh4,123$750,6551,225,443 total
  • Sale

    Common Stock

    2025-08-12$183.91/sh2,800$514,9471,167,391 total
  • Exercise/Conversion

    Employee Stock Option (right to buy) Holding

    2025-08-1266,5750 total
    Exercise: $57.31Exp: 2027-01-18Common Stock (66,575 underlying)
  • Exercise/Conversion

    Common Stock

    2025-08-12$57.31/sh+66,575$3,815,4131,229,566 total
  • Sale

    Common Stock

    2025-08-12$182.95/sh55,252$10,108,2821,170,191 total
  • Sale

    Common Stock

    2025-08-12$185.03/sh2,400$444,0741,164,991 total
  • Sale

    Common Stock

    2025-08-12$185.68/sh2,000$371,3521,162,991 total
  • Sale

    Common Stock

    2025-08-12$181.99/sh7,900$1,437,7032,093,805 total(indirect: CPEX)
  • Sale

    Common Stock

    2025-08-12$182.94/sh124,690$22,810,8511,969,115 total(indirect: CPEX)
  • Sale

    Common Stock

    2025-08-12$183.79/sh7,046$1,294,9791,962,069 total(indirect: CPEX)
  • Sale

    Common Stock

    2025-08-12$185.00/sh5,443$1,006,9581,956,626 total(indirect: CPEX)
  • Sale

    Common Stock

    2025-08-12$185.61/sh4,921$913,3981,951,705 total(indirect: CPEX)
Holdings
  • Common Stock

    (indirect: By Spouse)
    81,570
Footnotes (18)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 7, 2024.
  • [F10]The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
  • [F11]The price range for the aggregate amount sold by the direct holder is $181.47 - $182.46. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  • [F12]The price range for the aggregate amount sold by the direct holder is $182.49 - $183.48. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  • [F13]The price range for the aggregate amount sold by the direct holder is $183.49 - $184.48. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  • [F14]The price range for the aggregate amount sold by the direct holder is $184.49 - $185.48. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  • [F15]The price range for the aggregate amount sold by the direct holder is $185.50 - $185.85. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  • [F16]As previously reported, the reporting person also indirectly owns 1,951,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
  • [F17]As previously reported, the reporting person also indirectly owns 81,570 shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
  • [F18]These options are fully vested.
  • [F2]Amount of securities beneficially owned includes 83 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2025.
  • [F3]The price range for the aggregate amount sold by the direct holder is $181.54 - $182.53. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  • [F4]The price range for the aggregate amount sold by the direct holder is $182.54 - $183.53. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  • [F5]The price range for the aggregate amount sold by the direct holder is $183.55 - $184.54. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  • [F6]The price range for the aggregate amount sold by the direct holder is $184.55 - $185.54. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  • [F7]The price range for the aggregate amount sold by the direct holder is $185.59 - $185.85. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  • [F8]The common stock number referred in Table I is an aggregate number and represents 1,079,262 shares of common stock, 26,702 unvested restricted stock units ("RSUs"), and 57,027 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  • [F9]The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting.

Documents

1 file

Issuer

Intercontinental Exchange, Inc.

CIK 0001571949

Entity typeother

Related Parties

1
  • filerCIK 0001343882

Filing Metadata

Form type
4
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:30 PM ET
Size
28.9 KB